Marathon Trading Investment Management LLC C4 Therapeutics, Inc. Transaction History
Marathon Trading Investment Management LLC
- $358 Million
- Q2 2024
A detailed history of Marathon Trading Investment Management LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Marathon Trading Investment Management LLC holds 14,400 shares of CCCC stock, worth $86,400. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,400
Previous 64,000
77.5%
Holding current value
$86,400
Previous $522,000
87.36%
% of portfolio
0.02%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding CCCC
# of Institutions
122Shares Held
53.8MCall Options Held
331KPut Options Held
145K-
Ra Capital Management, L.P. Boston, MA4.88MShares$29.3 Million0.34% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT4.85MShares$29.1 Million0.12% of portfolio
-
Black Rock Inc. New York, NY4.55MShares$27.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.05MShares$24.3 Million1.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$21.3 Million0.0% of portfolio
About C4 Therapeutics, Inc.
- Ticker CCCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,913,800
- Market Cap $293M
- Description
- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...